The purpose of this study is to assess the therapeutic efficacy and safety of isosorbide dinitrate-oxytocin in combination in the management of late intrauterine foetal death.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Rates of uterine expulsion in the women who received the isosorbide dinitrate-oxytocin regimen
Timeframe: within 15 hours of administration